AuctuCel and CELLAAX Ink MoU to Advance Cell Therapy Innovation with Next-Generation Culture Media
AuctuCel Pte Ltd, a spinoff from A*STAR’s Bioprocessing Technology Institute, and CELLAAX Sdn Bhd, a biopharmaceutical company pioneering stem cell and immunotherapy solutions, have signed a Memorandum of Understanding (MoU) to jointly advance the development and manufacturing of cutting-edge cell therapies.
The MoU, signed on 26th June 2025 in Singapore, formalizes a collaboration that leverages AuctuCel’s proprietary media optimization technology and CELLAAX’s therapeutic expertise to improve the quality, consistency, and scalability of advanced cell-based treatments.
“This collaboration brings together CELLAAX’s deep therapeutic know-how and AuctuCel’s AI-powered media innovation,” said Dr Fhu Chee Wai, Co-founder and CEO of AuctuCel. “Together, we’re setting a new standard for precision-engineered media that supports not just cell growth, but translational success.”
Under the MoU, AuctuCel and CELLAAX will explore joint initiatives aimed at enhancing media development and application for cell therapy manufacturing. This includes the supply of ready-to-use and customized cell culture media, collaborative efforts in optimizing formulations for specific cell types, and joint research activities to evaluate performance and support process development. The partnership also opens pathways for future co-development of novel solutions and technologies, with the shared goal of accelerating the clinical and commercial readiness of advanced therapies.
“At CELLAAX, our goal is to make regenerative therapies more effective and accessible,” said Alex Wong, CEO of CELLAAX. “Reliable, high-performance media is essential to that mission. This partnership with AuctuCel strengthens our capabilities in manufacturing and scientific rigor, enabling us to bring better therapies to patients, faster.”
This collaboration represents a growing synergy between next-gen bioprocess innovation and therapeutic application — and a shared commitment to excellence in cell therapy manufacturing across Southeast Asia.
Media Contacts:
AuctuCel Pte Ltd
📧 hello@auctucel.com
🌐 www.auctucel.com
CELLAAX Sdn Bhd
📧 info@cellaaxtherapy.com
🌐 www.cellaaxtherapy.com